Browse the latest reports in the Pharmaceuticals industry below
-
Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players more info
GBI Research, the leading business intelligence provider, has released its latest research “Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players”. Japan’s pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10% of the world market. The industry grew from $62.8 billion in 2005 to its current value at a Compound Annual Growth Rate (CAGR) of 5.1%.By: GBI Research, Published: Apr-2013, Product code: GBIHC289MR
PAGES:
97
TABLES:
15
FIGURES & CHARTS:
57
$3,500.00 -
Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals more info
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2013. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.By: GlobalData, Published: Apr-2013, Product code: GDPH0385MD
PAGES:
68
TABLES:
44
FIGURES & CHARTS:
39
$1,000.00 -
Hyperlipidemia – Pipeline Review, H1 2013 more info
Global Markets Direct’s, 'Hyperlipidemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hyperlipidemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperlipidemia. Hyperlipidemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.By: Global Markets Direct, Published: Apr-2013, Product code: GMDHC3483IDB
PAGES:
99
TABLES:
38
FIGURES & CHARTS:
14
$2,000.00 -
Congestive Heart Failure (Heart Failure) – Pipeline Review, H1 2013 more info
Global Markets Direct’s, 'Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Congestive Heart Failure (Heart Failure), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Congestive Heart Failure (Heart Failure). Congestive Heart Failure (Heart Failure) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.By: Global Markets Direct, Published: Apr-2013, Product code: GMDHC3464IDB
PAGES:
353
TABLES:
92
FIGURES & CHARTS:
14
$2,000.00 -
Sarcomas – Pipeline Review, H1 2013 more info
Global Markets Direct’s, 'Sarcomas - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Sarcomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sarcomas. Sarcomas - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.By: Global Markets Direct, Published: Apr-2013, Product code: GMDHC3471IDB
PAGES:
292
TABLES:
63
FIGURES & CHARTS:
14
$2,000.00 -
Liver Fibrosis – Pipeline Review, H1 2013 more info
Global Markets Direct’s, 'Liver Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Liver Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver Fibrosis. Liver Fibrosis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.By: Global Markets Direct, Published: Apr-2013, Product code: GMDHC3480IDB
PAGES:
122
TABLES:
38
FIGURES & CHARTS:
14
$2,000.00 -
Age Related Macular Degeneration – Pipeline Review, H1 2013 more info
Global Markets Direct’s, 'Age Related Macular Degeneration - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Age Related Macular Degeneration, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Age Related Macular Degeneration. Age Related Macular Degeneration - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.By: Global Markets Direct, Published: Apr-2013, Product code: GMDHC3462IDB
PAGES:
387
TABLES:
109
FIGURES & CHARTS:
13
$2,000.00 -
T-Cell Lymphomas – Pipeline Review, H1 2013 more info
Global Markets Direct’s, 'T-Cell Lymphomas - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for T-Cell Lymphomas. T-Cell Lymphomas - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.By: Global Markets Direct, Published: Apr-2013, Product code: GMDHC3493IDB
PAGES:
222
TABLES:
43
FIGURES & CHARTS:
14
$2,000.00 -
Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H1 2013 more info
Global Markets Direct’s, 'Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Kidney Cancer (Renal Cell Cancer), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Kidney Cancer (Renal Cell Cancer). Kidney Cancer (Renal Cell Cancer) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.By: Global Markets Direct, Published: Apr-2013, Product code: GMDHC3469IDB
PAGES:
492
TABLES:
116
FIGURES & CHARTS:
14
$2,000.00 -
Inflammatory Bowel Disease – Pipeline Review, H1 2013 more info
Global Markets Direct’s, 'Inflammatory Bowel Disease - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Inflammatory Bowel Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Inflammatory Bowel Disease. Inflammatory Bowel Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.By: Global Markets Direct, Published: Apr-2013, Product code: GMDHC3460IDB
PAGES:
231
TABLES:
169
FIGURES & CHARTS:
14
$2,000.00
Refine Your Search
- Industry
- Price
- Publisher
- Region
- Report Type
Why buy direct from us?
Huge Selection
Industry Report Store has one of the largest databases of market research reports.
Instant Delivery
Most reports are available for immediate download upon purchase and full payment.
Best Price Guarantee
As we publish many of the reports ourselves, we set the prices and can offer special discounts.
All transactions are secured with SSL Security. 
Loading...